Equine Genomics: A New Frontier with Great Potential

 

March 8, 2006, Washington, D.C. – Ask most horse owners what they know about “equine genomics” and they are likely to guess that it is some new economical, easily-erected horse barn that is a geodesic dome-like structure based on the housing proposed by architect Buckminster Fuller.  Others might think it is a new name for the horses in the Lord of the Rings Trilogy.  But actually it is an important issue that the industry must understand and support because it could be the foundation for important equine research in the future.

 

Genomics is the study of the complex molecular chains that constitute an organism’s unique genetic heritage.  Mapping the genome (DNA) of the horse can broaden our understanding of what makes horses tick and produce wide-ranging applications in their breeding, care and health research. 

 

In the last ten years interest in genome research has focused on genomes of livestock and poultry to understand how various genes function and interact.  The 1990 Farm Bill officially recognized the potential of agricultural genomics when it authorized a U.S. Department of Agriculture Genetics Resources Program.  In 1993 the National Research Support Project was organized to coordinate the genome mapping efforts.  That effort now includes horses and includes Species Genome Committees.  The Horse Genome Coordinator is Dr. Ernest Bailey of the M.H. Gluck Equine Research Center of the University of Kentucky in Lexington, Kentucky.  Many other equine veterinarians and scientists have been working on the equine project for some time.

 

The USDA is responsible for supporting research on agriculturally-important animals, and the horse is clearly included in this group.  While significant support has been provided for horse genomics research, it lags significantly behind work supported for cattle, chickens, pigs, sheep and aquaculture.  Already, there is a complete genome sequence for cattle and chickens.  Genome sequencing is underway for pigs and sheep.  The USDA has been a strong advocate for this work.

 

One problem is the small size of the research community working on the horse.  Another problem is a bias within the agricultural community towards work on “food and fiber” animals.  The horse, providing neither, fares poorly when “food and fiber” is a criteria.  “However, the largest problem is the perception within the USDA that the horse industry does not support the use of genomics in research,” suggests American Horse Council President Jay Hickey. “Members of the horse industry need to articulate support for horse genomics as a lynch-pin in solving many of the major problems of equine health and welfare.”

 

The National Human Genome Research Institute recently announced that they would conduct a low level sequencing effort on the horse genome.  This work will provide DNA sequences for 80% of the horse genome.  “Such information will enable equine scientists to do significant work in the areas of gene expression, genetics, and functional genomics and permit research in physiology, immunology, nutrition, pharmacology, and metabolic diseases,” according to Dr. Bailey.

 

Currently, the horse gene map includes 2,000 genes or genetic markers that can be used in family studies to find genes responsible for diseases.  This is the approach used to identify the genes responsible for hyperkalemic periodic paralysis (HYPP), severe combined immunodeficiency disease (SCID), and overo lethal white foal syndrome (OLWFS).  But horse families cannot be readily assembled to study every hereditary trait of interest for the horse. Fortunately there is another approach, called an association study, that can circumvent this problem.  To pursue fully this research a complete horse genome sequence is needed. 

 

Federal funding is needed to supplement private funding to support continued research.  But support from the horse industry is needed and a clear message must be sent to Congress and the Department of Agriculture about the importance of genome sequencing.  Congress will begin putting together the next farm bill soon, even though it will not be considered until 2007.  Funding for genomics research will likely be included in that package.  “The horse industry must let Congress know that there is support for mapping the genes of horses,” said Hickey.  “Congress must be told the benefits that can be realized from this research to an industry that involves 9.2 million horses, has an economic impact of $102 billon on the U.S. economy and supports 1.4 million jobs, according to the American Horse Council national economic study.”

 

“The point is not to change the way that we breed and train horses.  Rather it is to make us more effective at what we already do.  With a complete mapping of the horse genome sequence we will see new drugs, vaccines, diagnostic tests, and management programs developed to benefit the health and welfare of horses,” noted Dr. Bailey.

 

Research into mapping the genomes of horses must continue.  For that to happen there must be support from the horse industry.